Michael Dougherty

Michael R.
Dougherty is currently Director at AltheRx, Inc. since 2013.
Former positions include President & Chief Executive Officer at Genaera Corp.
from 1998 to 2000; President, Chief Executive Officer & Director at Adolor Corp.
from 2006 to 2011; Chief Executive Officer & Director at Kalidex Pharmaceuticals, Inc. in 2012; Executive Chairman at Jazz Pharmaceuticals Therapeutics, Inc. from 2015 to 2016; Independent Director at Idera Pharmaceuticals, Inc.; Independent Director at Shire ViroPharma, Inc. from 2004 to 2014; Independent Director at Immedica Pharma US, Inc. from 2017 to 2022; Director at Cempra Pharmaceuticals, Inc.; Independent Director at Cempra, Inc. from 2013 to 2017; Independent Director at Trevena, Inc. from 2013 to 2023; Independent Director at Foundation Medicine, Inc. from 2016 to 2018; Independent Non-Executive Director at Aviragen Therapeutics, Inc. from 2013 to 2018; Independent Director at Aceragen, Inc. from 2022 to 2023; Director at ViralClear Pharmaceuticals, Inc.; Chief Financial Officer & Senior Vice President at Centocor, Inc. from 1983 to 1993; and President & Chief Operating Officer at Genomics Collaborative, Inc. from 2000 to 2002.
Education includes an undergraduate degree from Villanova University conferred in 1980.